Goldman Sachs
EPRX

Goldman Sachs’s Eupraxia Pharmaceuticals EPRX Stock Holding History

Goldman Sachs’s Portfolio EPRX Stock Details EPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$229K Buy
39,800
+5,300
+15% +$30.5K ﹤0.01% 4660
2025
Q1 		$113K Hold
34,500
– – ﹤0.01% 4798
2024
Q4 		$109K Hold
34,500
– – ﹤0.01% 4768
2024
Q3 		$90.7K Buy
+34,500
New +$90.7K ﹤0.01% 4611